PIMA515784
Influenza A H1N1 HA Monoclonal Antibody (7H12F6), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA515784-Each-of-1 | In Stock | ₹ 49,884.50 |
PIMA515784 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,884.50
GST (18%): ₹ 8,979.21
Total Price: ₹ 58,863.71
Antigen
Influenza A H1N1 HA
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Host Species
Mouse
Purification Method
Protein G
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG1
Applications
ELISA, Western Blot
Clone
7H12F6
Conjugate
Unconjugated
Gene Alias
flu hemagglutinin; H1N1 HA; H1N1 hemagglutinin; Influenza H1N1; influenza hemagglutinin
Immunogen
A synthetic peptide from the Hemagglutinin protein.
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20°C
Form
Liquid
Related Products
Description
- This antibody does not cross-react with swine-origin influenza A (S-OIV, H1N1) Hemagglutinin
- Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA
- In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States
- The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic
- Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins
- The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release
- These proteins also elicit immune responses that prevent infection or independently reduce viral replication
- The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin
- The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.